Correvio Pharma Corp. Proceeds from Common Stock Issued
Correvio Pharma Corp. reported Proceeds from Common Stock Issued of $26.99 million for the 12-month period ending 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2020-04-30
| Period end | Proceeds from Issuance of Common Stock 0 month | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|
| 2019-12-31 | $26.99M 20-F · filed 2020-04-30 | ||
| 2018-12-31 | $5.39M 20-F · filed 2020-04-30 | ||
| 2017-12-31 | $8.49M 20-F · filed 2020-04-30 | ||
| 2016-12-31 | $35.34M 20-F · filed 2018-04-30 | ||
| 2016-07-29 | $34.50M 20-F · filed 2018-04-30 | ||
| 2015-12-31 | $28.33M 20-F · filed 2018-04-30 | ||
| 2015-08-13 | $23.00M 20-F · filed 2018-04-30 | ||
| 2014-12-31 | $13.82M 40-F · filed 2016-03-29 | ||
| 2013-12-31 | $0.00 40-F · filed 2015-03-27 |